These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20603625)

  • 1. Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.
    Domschke K; Reif A; Weber H; Richter J; Hohoff C; Ohrmann P; Pedersen A; Bauer J; Suslow T; Kugel H; Heindel W; Baumann C; Klauke B; Jacob C; Maier W; Fritze J; Bandelow B; Krakowitzky P; Rothermundt M; Erhardt A; Binder EB; Holsboer F; Gerlach AL; Kircher T; Lang T; Alpers GW; Ströhle A; Fehm L; Gloster AT; Wittchen HU; Arolt V; Pauli P; Hamm A; Deckert J
    Mol Psychiatry; 2011 Sep; 16(9):938-48. PubMed ID: 20603625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder.
    Okamura N; Hashimoto K; Iyo M; Shimizu E; Dempfle A; Friedel S; Reinscheid RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1444-8. PubMed ID: 17669576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder.
    Domschke K; Ohrmann P; Braun M; Suslow T; Bauer J; Hohoff C; Kersting A; Engelien A; Arolt V; Heindel W; Deckert J; Kugel H
    Psychiatry Res; 2008 May; 163(1):13-20. PubMed ID: 18440204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of defensive reactivity in patients with panic disorder and agoraphobia: implications for the etiology of panic disorder.
    Richter J; Hamm AO; Pané-Farré CA; Gerlach AL; Gloster AT; Wittchen HU; Lang T; Alpers GW; Helbig-Lang S; Deckert J; Fydrich T; Fehm L; Ströhle A; Kircher T; Arolt V
    Biol Psychiatry; 2012 Sep; 72(6):512-20. PubMed ID: 22621998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional magnetic resonance imaging correlates of emotional word encoding and recognition in depression and anxiety disorders.
    van Tol MJ; Demenescu LR; van der Wee NJ; Kortekaas R; Marjan M A N; Boer JA; Renken RJ; van Buchem MA; Zitman FG; Aleman A; Veltman DJ
    Biol Psychiatry; 2012 Apr; 71(7):593-602. PubMed ID: 22206877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls.
    Gechter J; Liebscher C; Geiger MJ; Wittmann A; Schlagenhauf F; Lueken U; Wittchen HU; Pfleiderer B; Arolt V; Kircher T; Straube B; Deckert J; Weber H; Herrmann MJ; Reif A; Domschke K; Ströhle A
    Neuroimage Clin; 2019; 24():102029. PubMed ID: 31734525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia.
    Ridderbusch IC; Richter J; Yang Y; Hoefler M; Weber H; Reif A; Hamm A; Pané-Farré CA; Gerlach AL; Stroehle A; Pfleiderer B; Arolt V; Wittchen HU; Gloster A; Lang T; Helbig-Lang S; Fehm L; Pauli P; Kircher T; Lueken U; Straube B
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1138-1151. PubMed ID: 31444036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks.
    Thoeringer CK; Binder EB; Salyakina D; Erhardt A; Ising M; Unschuld PG; Kern N; Lucae S; Brueckl TM; Mueller MB; Fuchs B; Puetz B; Lieb R; Uhr M; Holsboer F; Mueller-Myhsok B; Keck ME
    J Psychiatr Res; 2007 Oct; 41(7):579-84. PubMed ID: 16904689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
    Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
    Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide S receptor gene: fear-specific modulations of prefrontal activation.
    Tupak SV; Reif A; Pauli P; Dresler T; Herrmann MJ; Domschke K; Jochum C; Haas E; Baumann C; Weber H; Fallgatter AJ; Deckert J; Ehlis AC
    Neuroimage; 2013 Feb; 66():353-60. PubMed ID: 23103692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders.
    Erhardt A; Lucae S; Unschuld PG; Ising M; Kern N; Salyakina D; Lieb R; Uhr M; Binder EB; Keck ME; Müller-Myhsok B; Holsboer F
    J Affect Disord; 2007 Aug; 101(1-3):159-68. PubMed ID: 17197037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.
    Kircher T; Arolt V; Jansen A; Pyka M; Reinhardt I; Kellermann T; Konrad C; Lueken U; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Wittchen HU; Straube B
    Biol Psychiatry; 2013 Jan; 73(1):93-101. PubMed ID: 22921454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene.
    Annerbrink K; Westberg L; Olsson M; Andersch S; Sjödin I; Holm G; Allgulander C; Eriksson E
    Psychiatr Genet; 2011 Apr; 21(2):85-9. PubMed ID: 21666548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide S receptor (NPSR1) gene variation modulates response inhibition and error monitoring.
    Beste C; Konrad C; Uhlmann C; Arolt V; Zwanzger P; Domschke K
    Neuroimage; 2013 May; 71():1-9. PubMed ID: 23319044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli.
    Dannlowski U; Kugel H; Franke F; Stuhrmann A; Hohoff C; Zwanzger P; Lenzen T; Grotegerd D; Suslow T; Arolt V; Heindel W; Domschke K
    Neuropsychopharmacology; 2011 Aug; 36(9):1879-85. PubMed ID: 21525857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic environmental intolerance: increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7.
    Binkley K; King N; Poonai N; Seeman P; Ulpian C; Kennedy J
    J Allergy Clin Immunol; 2001 May; 107(5):887-90. PubMed ID: 11344357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
    Bandelow B; Saleh K; Pauls J; Domschke K; Wedekind D; Falkai P
    World J Biol Psychiatry; 2010 Feb; 11(1):66-70. PubMed ID: 20146651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder.
    Politi P; Minoretti P; Falcone C; Martinelli V; Emanuele E
    Neurosci Lett; 2006 Mar; 396(2):163-6. PubMed ID: 16352396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased gray matter volume of the medial orbitofrontal cortex in panic disorder with agoraphobia: a preliminary study.
    Na KS; Ham BJ; Lee MS; Kim L; Kim YK; Lee HJ; Yoon HK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():195-200. PubMed ID: 23628432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.